On August 6, 2024, Silvana Battaglia, Executive Vice President of Cencora Inc (COR, Financial), sold 1,473 shares of the company. The transaction was reported in a recent SEC filing. After this sale, the insider now owns 10,948.08 shares of Cencora Inc.
Cencora Inc. is a leading healthcare company specializing in the development and distribution of pharmaceutical products. The company’s innovative approach has made it a major player in the pharmaceutical industry.
Over the past year, the insider has sold a total of 16,220 shares and made no purchases. This recent sale is part of a broader trend seen within the company. Over the past year, there were 32 insider sales and only one insider purchase.
Cencora Inc. shares were trading at $242.69 on the day of the sale. The company’s market capitalization is approximately $47.26 billion. Cencora Inc.’s price-to-earnings ratio is 26.18, which is higher than both the industry median of 16.965 and the company’s historical median.
The stock is valued at $207.43 according to GF Value, which corresponds to a price to GF Value ratio of 1.17. This suggests that Cencora Inc. is slightly overvalued at the current price.
The GF value is calculated based on historical trading multiples such as price-to-earnings ratio, price-to-sales ratio, price-to-book ratio and price-to-free cash flow, along with a GuruFocus adjustment factor based on past earnings and growth as well as Morningstar analysts’ views on future business performance.
This insider sale could be of interest to investors who track insider behavior and evaluate the stock’s current valuation metrics against historical performance and industry standards.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
